Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2016 Jan 22;138:81–89. doi: 10.1016/j.plefa.2016.01.001

Figure 2. RvD3 is produced in infectious exudates and matches synthetic compound.

Figure 2

Endogenous RvD3 was obtained from mice inoculated with E. coli (105 CFU; i.p.) and exudates collected at 24 hr. Exudates and synthetic material were subjected to lipid mediator metabololipodomics. (A and B) MS/MS spectrum for (A) endogenous RvD3; (B) coinjection of endogenous RvD3 from resolving exudate and synthetic RvD3. (C and D) Selected ion chromatograms (m/z 375-147) depict (C) murine-resolving exudate-derived RvD3 and (D) coinjection with synthetic material. Representative MRM chromatograms and MS-MS spectra (n=3).